Related Experiment Video

Updated: Jul 8, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[A case of mumps pneumonia complicated with acute respiratory failure]

K Fujita1, S Akutgawa, S Ikeda

  • 1Osaka Medical College, 2-7 Daigaku-machi, Takatsuki-City, Osaka, Japan.

Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society
|March 14, 2001
PubMed

Insights

This case report details adult mumps pneumonia, a rare complication of mumps virus infection. Prompt diagnosis and high-dose methylprednisolone therapy were crucial for recovery from acute respiratory failure.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Virology

Background:

  • Mumps virus typically causes parotitis but can lead to severe complications.
  • Adult mumps pneumonia is infrequently reported, especially in Japan.

Observation:

  • A 38-year-old male presented with dyspnea and swollen parotid glands, confirmed as mumps.
  • Computed tomography revealed ground-glass opacities in the lungs.
  • Bronchoalveolar lavage showed elevated lymphocytes and a decreased CD4+/CD8+ ratio.

Findings:

  • Bronchial biopsy confirmed lymphocytic infiltration, indicative of viral pneumonia.
  • The patient developed acute respiratory failure but improved with methylprednisolone.
  • This case represents the first documented instance of adult mumps pneumonia in Japan.

Implications:

  • Highlights mumps pneumonia as a differential diagnosis in adults with respiratory symptoms and mumps.
  • Suggests high-dose corticosteroids may be beneficial in managing severe mumps pneumonia.
  • Emphasizes the need for continued surveillance and research into mumps virus complications.

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...